Pardale-V Tablets for Dogs

< Back

Pardale-V is a non-prescription analgesic and anti-inflammatory medication for use in dogs. It is suitable for use after injuries or in other painful conditions. It is often used to help joint pain. It is not recommended to be given continuously; a 5 day course should be all that is needed, though repeat courses can be given after a suitable break. If in doubt, consult your veterinary surgeon. (NFA-VPS)

Read More...

  • Product Price QTY  
  • Pack of 100
    Estimated dispatch within 24 working hours.
    TVP: £33.24 Our price: £19.08 Buy
  • Pack of 500
    Estimated dispatch within 24 working hours.
    TVP: £152.47 Our price: £84.41 Buy

Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication.

Introduction

Dechra
Company name: Dechra Veterinary Products Limited
Address: (A business unit of Dechra Pharmaceuticals PLC)
Sansaw Business Park
Hadnall, Shrewsbury
Shropshire SY4 4AS
Telephone: 01939 211200
Fax: 01939 211201
Email: info@dechra-uk.com
Website: www.dechra.com

Presentation

White, flat tablets with a bevelled edge and a break-line.
Each tablet contains:
Active substances: Paracetamol 400 mg
Codeine phosphate hemihydrate 9 mg

Uses

For analgesic therapy in the dog only. The product is indicated for acute pain of traumatic origin, as a complementary treatment in pain associated with other conditions, and post operative analgesia.

Dosage and administration

For oral administration.
1 tablet per 12 kg body weight every 8 hours.
Small dogs (up to 6 kg body weight): Half a tablet every 8 hours.
Medium dogs (6-18 kg body weight): Half to one and a half tablets every 8 hours.
Large dogs (18-42 kg body weight): 1-3 tablets every 8 hours.
Treat for a maximum of 5 days.

Contraindications, warnings, etc

Do not exceed the stated dose or the duration of treatment.
Do not administer other NSAIDs concurrently or within 24 hours of each other.
Use is contraindicated in animals suffering from cardiac, hepatic or renal disease, where there is the possibility of gastrointestinal ulceration or bleeding, or where there is evidence of blood dyscrasia or hypersensitivity to the product.
Do not use this preparation for cats.
Use in animals less than 6 weeks of age, or in aged animals, may involve additional risk. If such use cannot be avoided, animals may require a reduced dosage and careful clinical management.
Avoid use in dehydrated, hypovolaemic or hypotensive animals as there is a potential risk of increased renal toxicity.
Some NSAIDS may be highly bound to plasma proteins and compete with other highly bound drugs to produce an increase in non-bound pharmacologically active concentrations, which can lead to toxic effects.
Concurrent administration of potentially nephrotoxic drugs should be avoided.
There are no known contraindications for use during pregnancy.
If you notice any serious effects or other effects not mentioned in the data sheet, please inform your veterinary surgeon.
Overdose: Immediately seek the advice of a veterinary surgeon showing them the product literature.
Carry out lavage and treat with an intravenous injection of acetylcysteine (200 mg/ml) at a rate of 140 mg/kg every 6 hours for 7 treatments. Ascorbic acid (30 mg/kg) should also be given orally with each dose of acetylcysteine. If necessary, instigate fluid therapy using 'Ringers' or bicarbonate solution. Treat for codeine overdosing with intravenous injections of naloxone (1.0 mg/kg) repeated as necessary. Provide oxygen support.
Side effects: Occasional constipation due to codeine content.
Special precautions to be taken by the person administering the veterinary medicinal product to animals: Wash hands after use.
General precautions: For animal treatment only.
Keep out of the reach and sight of children.

Pharmaceutical precautions

Do not store above 25C.
Do not use after the expiry date stated on the blister.
Disposal: Dispose of empty packaging and any remaining product in the household refuse.

Legal category

NFA-VPS

Packaging quantities

Containers of 100 and 500 tablets.

Further information

NSAIDs can cause inhibition of phagocytosis and hence in the treatment of inflammatory conditions associated with bacterial infections, appropriate concurrent antimicrobial therapy should be instigated.
Seek veterinary advice if the treated condition does not improve or worsens during treatment.
UK authorised veterinary medicinal product.

Marketing authorisation holder (if different from distributor)

Dechra Limited, Dechra House, Jamage Industrial Estate, Talke Pits, Stoke-on-Trent, Staffordshire, ST7 1XW.

Marketing authorisation number

Vm 10434/4034.

Need help or advice? Contact us:

  • Freephone: 0800 084 2608
  • Mon - Fri: 8:30am - 7:00pm
  • Sat: 10:00am - 3:00pm
  • Email: support@viovet.co.uk

All prices include VAT where applicable.

No Reviews For Pardale-V Tablets for Dogs

Have you tried Pardale-V Tablets for Dogs? Be the first to write a review!

Write a Review!
AJAX:/family.ajax?mode=tab_delivery

Ask your own question about Pardale-V Tablets for Dogs

There are currently no questions for Pardale-V Tablets for Dogs, be the first to ask one!





Thank you for your question regarding Pardale-V Tablets for Dogs, you will receive an email when a member of our team provides an answer.